Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06779552

CardioMEMS HF System Coverage With Evidence Development Study

The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Abbott

Pleasanton, California, 94588, United States

Location status: Recruiting

Location contact

Nessa Johnson

CONTACT

[email protected]

612-283-3865

About this study

The CardioMEMS CED Study will assess 2-year HF hospitalization rates and survival for all-cause mortality in heart failure subjects managed with the CardioMEMS HF system, as compared to a contemporaneous control of HF subjects managed without PA pressure-guidance.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject implanted with a CardioMEMS pressure sensor (treatment arm only)
  • Subject >=18 years of age at time of implant
  • Subject has a history of acute decompensated HF or HF-related congestion defined by at least one of the following qualifying event types: HF hospitalization, elevated BNP/NT-proBNP

Exclusion criteria

  • Subject has history of heart transplant or durable mechanical circulatory device
  • Subject hospitalized with cardiogenic shock or sepsis
  • Subject received prior PA pressure sensor implant (control arm only)

Treatment and study plan

CardioMEMS HF System

Device

PA Pressure Sensor

Primary outcomes

  1. HF Hospitalization Rate.

    Time frame: 2 years

    Compare HF hospitalization rate between the treatment and control groups.

Secondary outcomes

  1. Two-Year Survival

    Time frame: 2 years

    Compare survival between the treatment and control groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Nessa Johnson

CONTACT

[email protected]

612-283-3865

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Important dates

Study start
2025
Primary completion
2032
Study completion
2032
First posted
Jan 16, 2025
Registry last updated
Apr 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.